Home › Funds › Summit Creek Advisors LLC › LMAT

Summit Creek Advisors LLC position in LMAT

LEMAITRE VASCULAR INC · Health Care

Summit Creek Advisors LLC reported holding 49,624 shares of LMAT (LEMAITRE VASCULAR INC) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 1.71% of its reported portfolio and ranking #30 among its reported holdings. Summit Creek Advisors LLC has disclosed LMAT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)49.62K sh
Reported value held$4.10M
Portfolio Weight1.71%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Summit Creek Advisors LLC's LMAT position evolved

Summit Creek Advisors LLC first disclosed a stake in LMAT in Q3 2023 at 165,764 shares (US$9.0M). The position peaked in Q3 2024 at 202,766 shares, worth US$18.8M. Across 13 filings, Summit Creek Advisors LLC increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 49,624 shares valued at US$4.1M — an increase of 450 shares quarter over quarter.. Notable position changes include a 38% increase in Q4 2023 (shares rose 17% over the following quarter), a 30% trim in Q1 2026 (shares fell 12% over the following quarter), a 53% trim in Q2 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 165.76K $9.03M New
Q4 2023 228.50K $12.97M Add
Q1 2024 229.94K $15.26M Add
Q2 2024 215.00K $17.69M Reduce
Q3 2024 202.77K $18.83M Reduce
Q4 2024 175.86K $16.20M Reduce
Q1 2025 175.69K $14.74M Hold
Q2 2025 168.38K $13.98M Reduce
Q3 2025 155.90K $13.64M Reduce
Q4 2025 150.00K $12.16M Reduce
Q1 2026 105.68K $11.54M Reduce
Q2 2026 49.17K $4.72M Reduce
Q3 2026 49.62K $4.10M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LMAT and 13F data

LMAT (LEMAITRE VASCULAR INC) is a Health Care company. 34 other funds we track also report a position in LMAT — the largest reported positions include Copeland Capital Management, LLC (US$76.3M), Conestoga Capital Advisors, LLC (US$72.6M), GENEVA CAPITAL MANAGEMENT LLC (US$42.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LMAT

All LMAT fund holders →

FAQ

How long has Summit Creek Advisors LLC held LMAT?

Summit Creek Advisors LLC has disclosed LMAT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Summit Creek Advisors LLC's current position in LMAT?

As of Q3 2026, Summit Creek Advisors LLC holds 49.62K shares of LMAT (LEMAITRE VASCULAR INC), valued at $4.10M, representing 1.71% of its reported portfolio and ranking #30.

Has Summit Creek Advisors LLC been buying or selling LMAT?

In the latest 13F filing (Q3 2026), Summit Creek Advisors LLC increased its position in LMAT. The position peaked in Q3 2024 at 202.77K shares.

Which other funds hold LMAT?

Other major institutional holders of LMAT include Copeland Capital Management, LLC, Conestoga Capital Advisors, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.